APA (7th ed.) Citation

Delgado, J., Papadouli, I., Sarac, S. B., Moreau, A., Hovgaard, D., Gisselbrecht, C., . . . Pignatti, F. (2021). The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma. Wolters Kluwer.

Chicago Style (17th ed.) Citation

Delgado, Julio, Irene Papadouli, Sinan B. Sarac, Alexandre Moreau, Doris Hovgaard, Christian Gisselbrecht, Harald Enzmann, and Francesco Pignatti. The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma. Wolters Kluwer, 2021.

MLA (8th ed.) Citation

Delgado, Julio, et al. The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma. Wolters Kluwer, 2021.